Table 1. Summary of the 74 RCC patients involved in this study.
Age | ||
Mean ± SD, year | 56.22 ± 13.32 | |
<60 | 42 | 56.8% |
≥60 | 32 | 43.2% |
Gender | ||
Male | 47 | 63.5% |
Female | 27 | 39.5% |
Tumor size | ||
≤4 | 42 | 56.8% |
>4 | 32 | 43.2% |
Histology | ||
Clear cell carcinoma | 61 | 82.4% |
Others | 13 | 17.6% |
Histological grade | ||
I | 15 | 20.3% |
II | 47 | 63.5% |
III | 9 | 12.2% |
IV | 3 | 4.0% |
Tumor stage | ||
T1 | 64 | 86.5% |
T2 | 6 | 8.1% |
T3 | 4 | 5.4% |
Survival | ||
Mean ± SD, month | 60.73 ± 18.27 | |
No | 13 | 17.6% |
Yes | 61 | 82.4% |
CAPN2 expression | ||
Low | 50 | 67.6% |
High | 24 | 32.4% |
SD, standard deviation.